Canadian natural health products system
This article was originally published in The Tan Sheet
Executive Summary
Labeling, product/site licensing, GMPs, adverse event reporting, definitions and clinical trials are among provisions in proposed regulatory framework slated for publication in Canada Gazette Dec. 22. Proposed regs, announced by Health Canada Dec. 20, follow agency's establishment of Natural Health Products Directorate in 1999 (1"The Tan Sheet" Nov. 30, 1998, p. 6). Comments on proposed measures will be accepted for 90 days...
You may also be interested in...
Canada Natural Health Products New Regulatory Scheme Proposed
Canada's House of Commons Standing Committee on Health recommends the government create a new regulatory division for natural health products reporting to the Assistant Deputy Minister of the Health Protection Branch.
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.